Search Thermo Fisher Scientific
Search Thermo Fisher Scientific
Learn how to benefit from recent technology advances to successfully develop your bioprocess.
Learn how some key early technology choices can positively impact your bioprocess development agility and time to clinic.
Watch this educational webinar and discover valuable risk mitigation strategies addressing important issues such as integrity or particulates, both in the area of rigid or flexible single-use systems.
Learn how to benefit from recent technology advances to develop or improve your vaccine’s downstream bioprocess, either microbial or animal cells based.
In this webinar, Thermo Fisher Scientific describe how they are mobilizing to meet rapidly growing demand for AAV vector from both technology development and manufacturing strategy viewpoints.
Watch this educational webinar and learn about the benefits of implementing affinity chromatography in the downstream purification of viral vectors
Discussed here are results from a series experiments in which in-process mAb material was spiked with MVM-MVP and processed through Anion Exchange and Cation Exchange.
In this webinar, we share the development and validation of a new, and highly sensitive and accurate solution for detecting and quantifying residual HEK293 host cell DNA to help meet regulatory requirements.
Hear from our experts: A retrospective look at past Mycoplasma validation queries and responses
This webinar focuses on POROS Ion Exchange and Hydrophobic Interaction chromatography resins, addressing purification challenges of today’s biomolecules.
Watch this webinar and learn more about validation of a qPCR assay for residual host cell DNA quantitation.
Research and development, process development, and pilot plants involved in scale-up and technology transfer can face significant setbacks such as time and data loss due to a lack of efficient, traceable data transfer.
This video is part 1 of 2 videos that cover the unpacking and inspection of Thermo Scientific BioProcess Containers (BPCs).
This video is part 2 of 2 videos that cover the unpacking and inspection of Thermo Scientific BioProcess Containers (BPCs).
As the market develops a need for more open and flexible systems, special attention should be paid to how your bioprocess equipment meets both present and future facility and process requirements.
A case study demonstrates that affinity chromatography can offer efficiency and scalability for gene therapy manufacturing using viral vectors.
Protein purification is a tricky business. Read the article to find out more on affinity chromatography purification.
As the market develops a need for more open and flexible systems, special attention should be paid to how your bioprocess equipment meets both present and future facility and process requirements.
Original developers of biosolutions and products, especially those facing the debut of biosimilars in core markets, have an urgent imperative to reduce manufacturing costs via increased productivity and yields. In turn, this drives a wide range of business decisions, including capital investment, process choices and design, and equipment selection.
Generation of bispecifc antibodies (BsAbs) having two unique Fab domains requires heterodimerization of the two heavy chains and pairing of each heavy chain with its cognate light chain.
Learn more about Capture Select technology minimizing the steps in the purification process.
The quality of raw materials needs to be considered according to the stage of development of the cell or gene therapy.
Hydrophobic interaction chromatography (HIC) in flow-through mode offers a more efficient and cost-effective polishing/purification process.
Single-use technology (SUT) products are beneficial in the manufacturing of vaccines and biologics.
Thermo Scientific Labtainer Pro BPC was developed to meet a variety of bioproduction workflow needs.
Biologics have transformed patient treatment by offering new and effective medicines for a range of chronic and acute conditions.
Five Myths Vs. Reality for Microbial testing.
Using the POROS resins, a HIC step can be easily implemented resulting in increased yields and reduced processing times through effective and efficient removal of impurities.
Enabling advancement of gene therapies in the clinic.
Find out more about the development of a novel residual DNA assay for HEK-293.
Manufacture of Commercial-Scale Next-Generation Antibody Therapies
Production processes have become more efficient because common purification processes are being used across structurally similar MAbs during key steps of process development and manufacturing.
This article focuses on key regulatory considerations and requirements across the cell and gene therapy raw and starting materials area.
With the advancement of gene delivery vectors and gene editing technologies, cell and gene therapies are a very real solution to many previously untreatable or difficult to treat diseases
Growing competition across the biomanufacturing industry is resulting in a greater need for efficiency and speed at all stages of development and manufacturing. Read the full application note.
Access a targeted collection of scientific application notes, case studies, posters, white papers and more for bioprocessing: